Hambrecht & Quist Capital Management »

Chinook Therapeutics shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Chinook Therapeutics shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Chinook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chinook Therapeutics held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chinook Therapeutics by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $5.8M 151k 38.42
2023-03-31 $1.9M 84k 23.15

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Chinook Therapeutics

Farther Finance Advisors
Parallel Advisors

View all funds holding Chinook Therapeutics